A hospice in Morovis, PR. It ran an operating surplus of 12.7% in FY24 on $2.6M of operating revenue. It held 350 days of cash on hand (93rd percentile among hospices on liquidity). Operating margin declined from 14.1% in FY20 to 12.7% in FY24. It carries an average daily census of 57.
Average daily census
57
Verified fact2024
Source: CMS Hospice
Hospice Care Index
9
Verified fact2024
Source: CMS Hospice Quality
Operating margin · FY24
+12.7%
▼ 1.6 pts vs FY23
vs hospices74th pctl of 3,488 (FY24)
Total days of care
20957.0d
Verified fact2024
Source: HCRIS CMS-1984
Where HOSPICIO LA MILAGROSA, sits among hospices
Operating margin · FY24 pool · n = 3,488 of 5,626 filed
Each point is one hospice in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The hospice median is +0.1%. Descriptive context only, not a ranking.
One hospiceHOSPICIO LAhospice median
The money
$ thousands · HCRIS cost-report basis · as filed, QA-gated
Ratios tell you how this hospice is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.
Operating margin
+12.7% (FY24)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
+12.7% (FY24)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
350d (FY24)
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
11.57× (FY24)
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
6% (FY24)
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
74d (FY24)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line item
FY22
FY23
FY24
Patient revenue
2,357
2,566
2,568
Total operating revenue
2,357
2,566
2,568
Total operating expenses
1,996
2,198
2,242
Operating income
361
368
326
Operating margin %
+15.3%
+14.3%
+12.7%
Other non-operating, net
0
1
1
Net income
361
369
327
Net income %
+15.3%
+14.4%
+12.7%
HCRIS CMS-1984 cost report · $ thousands · FY20–FY24 · patient-service operating basis; non-patient revenue (contributions, investment) is non-operating · FY20–21 may include COVID-era relief funding
How it operates
quality & operational context · CMS public reporting
The metrics this hospice type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.
Hospice Care Index
9
Verified fact2024
CMS Hospice Quality
Average daily census
57
Verified fact2024
CMS Hospice
Routine home care mix
100.0%
Verified fact2024
HCRIS CMS-1984
Continuous home care mix
0.0%
Verified fact2024
HCRIS CMS-1984
Total days of care
20957.0d
Verified fact2024
HCRIS CMS-1984
General inpatient mix
0.0%
Verified fact2024
HCRIS CMS-1984
Respite mix
0.0%
Verified fact2024
HCRIS CMS-1984
Trajectory
Cost-report basis · 5 reporting years
Operating margin
Days cash on hand
The county this hospice serves
Morovis Municipio, PR
Located in Morovis, PR. County demographic and economic context (Census, CDC, HRSA sources) extends to this hospice cohort in an upcoming release.
Opportunity screen · FY24
≈ $1.3M
of annual opportunity identified against peer medians across 1 measure
Directional, conservative band. Arithmetic against matched-peer medians from public filings, not a projection; public data cannot fully control for patient acuity.
The free profile shows the record. The Board Briefing tells you what changed, what matters, and what your board should ask. 35+ pages, built entirely from public sources, no client data required. Delivered within 2 business days. If we cannot deliver the published scope for your facility, you pay nothing.
Where this facility is underperforming its matched peer cohort and what that gap is worth, measure by measure. Founding Edition: delivered within 30 days of eligibility confirmation, full refund if the published scope cannot be delivered.
